P0C6F2 (POL_HV1LW) Human immunodeficiency virus type 1 group M subtype B (isolate LW123)(HIV-1)

Gag-Pol polyprotein UniProtKBInterProInteractive Modelling

1435 aa; Sequence (Fasta)

Available Structures

12 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
HIV-1 Reverse Transcriptase in complex with a 2,6-difluorophenyl DAPY analog Heteromer
P04585;
593-1016
IB1;
Assess
HIV integrase in complex with inhibitorhomo-2-mer1203-1357
4BI;CD;
Assess
HIV protease in complex with AA74homo-2-mer489-587
23L;EDO;CL;
Assess
HIV protease in complex with SA499homo-2-mer489-587
23K;EDO;CL;
Assess
Crystal Structure of HIV-1 Protease Mutant Q7K V32I L63I with a cyclic sulfonamide inhibitorhomo-2-mer489-587
9Y9;
Assess
HIV protease in complex with SA526Phomo-2-mer489-587
CL;526;
Assess
Crystal Structure of HIV-1 Protease Mutant V82A with novel P1'-Ligands GRL-02031homo-2-mer489-587
031;NA;CL;
Assess
HIV protease in complex with SA525Phomo-2-mer489-587
525;CL;
Assess
Crystal structure of wild type HIV-1 protease in complex with non-peptidic inhibitor, GRL008homo-2-mer489-587
G08;
Assess
X-ray crystal structure of HIV-1 protease variant G48T/L89M in complex with Saquinavirhomo-2-mer489-587
ROC;GOL;
Assess
Crystal structure of wild type HIV-1 protease in complex with non-peptidic inhibitor, GRL007homo-2-mer489-587
G07;
Assess
p15 HIV RNaseH domain with inhibitor MK3monomer1014-1143
MN;LP9;
Assess

6 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6v3k.3.Ahomo-4-mer0.731163-1424
91.94
Assess
7sep.1.Ahomo-2-mer0.71591-1140
99.48
Assess
7t15.1.Ehomo-6-mer0.71133-352
84.42
Assess
1l6n.1.Amonomer0.702-283
95.05
Assess
5u1c.1.Ahomo-4-mer0.701163-1416
91.58
Assess
7asl.1.Ahomo-18-mer0.65143-377
99.57
Assess